University of Helsinki, Helsinki 2004
A novel enzymic therapy, targeted recombinant beta-lactamase, in the prevention of antibiotic-induced adverse effects on gut microbiota
Academic Dissertation, February 2004.
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
© University of Helsinki 2004
Viimeksi päivitetty 08.02.2004/JH